CoChat

Depressive symptoms predict clinical recurrence of ­inflammatory bowel disease

Open access
Jordi, Sebastian Bruno Ulrich, Lang, Brian Matthew, Auschra, Bianca, von Känel, Roland, Biedermann, Luc, Greuter, Thomas, Schreiner, Philipp, Rogler, Gerhard, Krupka, Niklas, Sulz, Michael Christian, Misselwitz, Benjamin, Begré, Stefan, Swiss IBD Cohort Study Group, Anderegg, Claudia, Bauerfeind, Peter, Beglinger, Christoph, Begré, Stefan, Belli, Dominique, Bengoa, José M, Biedermann, Luc, Bigler, Beat, Binek, Janek, Blattmann, Mirjam, Boehm, Stephan, Borovicka, Jan, Braegger, Christian P, Brunner, Nora, Bühr, Patrick, Burnand, Bernard, Burri, Emanuel, Buyse, Sophie, Cremer, Matthias, Criblez, Dominique H, de Saussure, Philippe, Degen, Lukas, Delarive, Joakim, Doerig, Christopher, Dora, Barbara, Dorta, Gian, Egger, Mara, Ehmann, Tobias, El-Wafa, Ali, Engelmann, Matthias, Ezri, Jessica, Felley, Christian, Fliegner, Markus, Fournier, Nicolas, Fraga, Montserrat, Frei, Pascal, Frei, Remus, Fried, Michael, Froehlich, Florian, Funk, Christian, Furlano, Raoul Ivano, Gallot-Lavallée, Suzanne, Geyer, Martin, Girardin, Marc, Golay, Delphine, Grandinetti, Tanja, Gysi, Beat, Haack, Horst, Haarer, Johannes, Helbling, Beat, Hengstler, Peter, Herzog, Denise, Hess, Cyrill, Heyland, Klaas, Hinterleitner, Thomas, Hiroz, Philippe, Hirschi, Claudia, Hruz, Petr, Iwata, Rika, Jost, Res, Juillerat, Pascal, Brondolo, Vera Kessler, Knellwolf, Christina, Knoblauch, Christoph, Köhler, Henrik, Koller, Rebekka, Krieger-Grübel, Claudia, Kullak-Ublick, Gerd, Künzler, Patrizia, Landolt, Markus, Lange, Rupprecht, Lehmann, Frank Serge, Macpherson, Andrew, Maerten, Philippe, Maillard, Michel H, Manser, Christine, Manz, Michael, Marbet, Urs, Marx, George, Matter, Christoph, McLin, Valérie, Meier, Rémy, Mendanova, Martina, Meyenberger, Christa, Michetti, Pierre, Misselwitz, Benjamin, Moradpour, Darius, Morell, Bernhard, Mosler, Patrick, Mottet, Christian, Müller, Christoph, Müller, Pascal, Müllhaupt, Beat, Münger-Beyeler, Claudia, Musso, Leilla, Nagy, Andreas, Neagu, Michaela, Nichita, Cristina, Niess, Jan, Noël, Natacha, Nydegger, Andreas, Obialo, Nicole, Oneta, Carl, Oropesa, Cassandra, Peter, Ueli, Peternac, Daniel, Petit, Laetitia Marie, Piccoli-Gfeller, Franziska, Pilz, Julia Beatrice, Pittet, Valérie, Raschle, Nadia, Rentsch, Ronald, Restellini, Sophie, Richterich, Jean-Pierre, Rihs, Sylvia, Ritz, Marc Alain, Roduit, Jocelyn, Rogler, Daniela, Rogler, Gerhard, Rossel, Jean-Benoît, Sagmeister, Markus, Saner, Gaby, Sauter, Bernhard, Sawatzki, Mikael, Schäppi, Michela, Scharl, Michael, Schelling, Martin, Schibli, Susanne, Schlauri, Hugo, Uebelhart, Sybille Schmid, Schnegg, Jean-François, Schoepfer, Alain, Seibold, Frank, Seirafi, Mariam, Semadeni, Gian-Marco, Semela, David, Senning, Arne, Sidler, Marc, Sokollik, Christiane, Spalinger, Johannes, Spangenberger, Holger, Stadler, Philippe, Steuerwald, Michael, Straumann, Alex, Straumann-Funk, Bigna, Sulz, Michael, Thorens, Joël, Tiedemann, Sarah, Tutuian, Radu, Vavricka, Stephan, Viani, Francesco, Vögtlin, Jürg, von Känel, Roland, Vonlaufen, Alain, Vouillamoz, Dominique, Vulliamy, Rachel, Wermuth, Jürg, Werner, Helene, Wiesel, Paul, Wiest, Reiner, Wylie, Tina, Zeitz, Jonas, Zimmermann, Dorothee · 2022 · Inflammatory Bowel Diseases

Published version of a preprint

The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index; 3 of the 28 sources its claims cite were checked for support.

Abstract

BACKGROUND: Inflammatory bowel disease (IBD) patients are at high risk for depression, and depression has been shown to affect disease course. We examined interrelations between depression, genetic risk factors for depression, and IBD flares. METHOD: In 1973 patients (1137 Crohn's disease, 836 ulcerative colitis) of the Swiss IBD Cohort Study (SIBDCS), depressive status (hospital anxiety and depression subscale for depression, HADS-D ≥11) was assessed on a yearly basis. We investigated the impact of depression on IBD-relevant clinical outcomes in Cox proportional hazards models. We used active disease (CDAI ≥150 or MTWAI ≥10) and 2 published composite flare definitions-FNCE (physician-reported flare, nonresponse to therapy, new complication, or extraintestinal manifestation) and AFFSST (active disease, physician-reported flare, fistula, stenosis, and new systemic therapy)-as clinical end points. Additionally, 62 preselected single nucleotide polymorphisms (SNPs) were screened for cross-sectional associations with depression, and if present, their predictive value for future depression and clinical deterioration was assessed. RESULTS: Depression was a strong risk factor for disease-related end points, including active disease (adjusted hazard ratio [aHR], 3.55; P < 0.001), AFFSST (aHR, 1.62; P < 0.001), and FNCE (aHR, 1.35; P = 0.019). The SNP rs2522833 was significantly associated with depression at enrollment (q = 0.059). The TC allele of rs588765 was negatively associated with the presence of depression at enrollment (q = 0.050) and after enrollment (aHR, 0.67; P = 0.035) and with fewer active disease states (aHR, 0.72; P = 0.045) during follow-up. CONCLUSION: In IBD, depressive symptoms and inflammatory activity are intimately related. Depressive symptoms were a strong predictor of clinical deterioration, and genetic markers may play a role in this relationship.

Overview

CoChat Summary

TL;DR

In this Swiss IBD cohort study, depressive symptoms at a visit predicted later clinical worsening of IBD, including active disease and composite flare outcomes. The study also found that rs588765-TC was associated with less depression and less IBD activity over time, while rs2522833’s C allele was associated with depressive symptoms at baseline.

Key findings

  • In 1973 genotyped SIBDC patients (1137 Crohn’s disease, 836 ulcerative colitis/IC), depressive symptoms at follow-up were associated with later active disease: adjusted hazard ratio (aHR) 3.25, p<0.001.
  • Depressive symptoms also predicted the composite flare endpoints: AFFSST (aHR 1.62, p<0.001) and FNCE (aHR 1.35, p=0.019).
  • Of 62 SNPs tested after linkage-disequilibrium pruning from 95 to 62, two SNPs were associated with depressive symptoms at baseline (q<0.1): rs588765-TC was protective (OR 0.43, q=0.050 after variable elimination) and rs2522833’s C allele increased odds of depression (OR 1.73, q=0.059).
  • In time-to-event analyses, rs588765-TC remained protective for new or persistent depressive symptoms (aHR 0.67, p=0.035) and was also associated with fewer active disease states during follow-up (aHR 0.72, p=0.045); rs2522833 was not significantly associated with outcomes over time.

Methods

  • Prospective cohort analysis within the Swiss IBD cohort study, which recruits nationwide in Switzerland and follows patients yearly; only genotyped patients with available biomaterial were included.
  • Baseline and follow-up data were available for 1973 genotyped patients; depressive symptoms were defined as HADS-D ≥ 11, and disease activity used CDAI ≥ 150 for Crohn’s disease or MTWAI ≥ 10 for ulcerative colitis/IC.
  • The authors screened 62 SNPs for association with depression using logistic regression, then tested depression and SNP effects on time-to-event outcomes with Cox proportional hazards models, including multivariable adjustment.

Limitations

  • The paper states that the genetic analyses had a relatively small sample size, which reduced statistical power.
  • The paper states that missing data points, such as therapy or surgery data, further reduced statistical power.
  • The paper states that HADS-D ≥ 11 indicates probable depression, but a true depression diagnosis normally requires direct clinical assessment by a psychiatrist.
  • Evident from the text: this is an observational cohort study, so the reported associations cannot by themselves establish causality.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1093/ibd/izab136

Cites

72 of 72 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

3 Valid · 0 Not valid · 13 Not checked · 67 Own results and interpretations

40 more claims

Create a free account to see all 83 claims and to verify the 25 references still open.

See all claims — free account
  • Probably not a substantial claim. 29
  • It may state two separate claims as one. 11
  • The quote only partly states this claim. 3

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 4

  1. National Cancer Institute (NCI), ., NCI’s Dictionary of Genetics Terms.
  2. Therneau, 2020, A Package for Survival Analysis in R
  3. Baer, 2013, Depressionen in der Schweizer Bevölkerung: Daten zur Epidemiologie, Behandlung und sozial-beruflichen Integration
  4. Kessler, 2009, Epidemiology of depression, 5

Cited by

See all 45

Metadata

Authors
Jordi, S. B. U., Lang, B. M., Auschra, B., von Känel, R., Biedermann, L., Greuter, T., Schreiner, P., Rogler, G., Krupka, N., Sulz, M. C., Misselwitz, B., Begré, S., Swiss IBD Cohort Study Group, Anderegg, C., Bauerfeind, P., Beglinger, C., Begré, S., Belli, D., Bengoa, J. M., Biedermann, L., Bigler, B., Binek, J., Blattmann, M., Boehm, S., Borovicka, J., Braegger, C. P., Brunner, N., Bühr, P., Burnand, B., Burri, E., Buyse, S., Cremer, M., Criblez, D. H., de Saussure, P., Degen, L., Delarive, J., Doerig, C., Dora, B., Dorta, G., Egger, M., Ehmann, T., El-Wafa, A., Engelmann, M., Ezri, J., Felley, C., Fliegner, M., Fournier, N., Fraga, M., Frei, P., Frei, R., Fried, M., Froehlich, F., Funk, C., Furlano, R. I., Gallot-Lavallée, S., Geyer, M., Girardin, M., Golay, D., Grandinetti, T., Gysi, B., Haack, H., Haarer, J., Helbling, B., Hengstler, P., Herzog, D., Hess, C., Heyland, K., Hinterleitner, T., Hiroz, P., Hirschi, C., Hruz, P., Iwata, R., Jost, R., Juillerat, P., Brondolo, V. K., Knellwolf, C., Knoblauch, C., Köhler, H., Koller, R., Krieger-Grübel, C., Kullak-Ublick, G., Künzler, P., Landolt, M., Lange, R., Lehmann, F. S., Macpherson, A., Maerten, P., Maillard, M. H., Manser, C., Manz, M., Marbet, U., Marx, G., Matter, C., McLin, V., Meier, R., Mendanova, M., Meyenberger, C., Michetti, P., Misselwitz, B., Moradpour, D., Morell, B., Mosler, P., Mottet, C., Müller, C., Müller, P., Müllhaupt, B., Münger-Beyeler, C., Musso, L., Nagy, A., Neagu, M., Nichita, C., Niess, J., Noël, N., Nydegger, A., Obialo, N., Oneta, C., Oropesa, C., Peter, U., Peternac, D., Petit, L. M., Piccoli-Gfeller, F., Pilz, J. B., Pittet, V., Raschle, N., Rentsch, R., Restellini, S., Richterich, J.-P., Rihs, S., Ritz, M. A., Roduit, J., Rogler, D., Rogler, G., Rossel, J.-B., Sagmeister, M., Saner, G., Sauter, B., Sawatzki, M., Schäppi, M., Scharl, M., Schelling, M., Schibli, S., Schlauri, H., Uebelhart, S. S., Schnegg, J.-F., Schoepfer, A., Seibold, F., Seirafi, M., Semadeni, G.-M., Semela, D., Senning, A., Sidler, M., Sokollik, C., Spalinger, J., Spangenberger, H., Stadler, P., Steuerwald, M., Straumann, A., Straumann-Funk, B., Sulz, M., Thorens, J., Tiedemann, S., Tutuian, R., Vavricka, S., Viani, F., Vögtlin, J., von Känel, R., Vonlaufen, A., Vouillamoz, D., Vulliamy, R., Wermuth, J., Werner, H., Wiesel, P., Wiest, R., Wylie, T., Zeitz, J., & Zimmermann, D.
Affiliations
  • University of Bern (CH)
  • University Hospital of Basel (CH)
  • University of Zurich (CH)
  • Department of Gastroenterology and Hepatology, Kantonsspital St. Gallen , St. Gallen , Switzerland
  • Kantonsspital St. Gallen (CH)
Venue
Inflammatory Bowel Diseases
Published
2021-06-07
Volume
28
Issue
4
Pages
560-571
ISSN
  • 1078-0998 (ISSN-L)
  • 1536-4844
OpenAlex
W3166723635
Cited by
41
References
72
Citations by year
2026: 4 · 2025: 11 · 2024: 6 · 2023: 8 · 2022: 10 · 2021: 2
FWCI
3.67
Type
journal article
Language
en
Open access
Locations
  • Inflammatory Bowel Diseases (publishedVersion)
  • medRxiv (acceptedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • BORIS (University Library Bern) (submittedVersion)
  • IRIS (submittedVersion)
  • SERVAL (Université de Lausanne) (submittedVersion)
  • Zurich Open Repository and Archive (University of Zurich) (submittedVersion)
Funders
Swiss National Science Foundation (33CS30-148422)
Topics
  • Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
  • Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
Keywords
inflammatory bowel disease, depression
MeSH terms
Cross-Sectional Studies, Depression, Humans, Recurrence, Inflammatory Bowel Diseases, Cohort Studies, Polymorphism, Single Nucleotide

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.